Vericel Corp.

... ...
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Medical Specialties
TMOThermo Fisher Scientific, Inc. -0.67%512.411.0%$765.61m
DHRDanaher Corp. -1.66%233.120.7%$541.14m
ABTAbbott Laboratories 0.06%112.960.8%$468.53m
ISRGIntuitive Surgical, Inc. 0.01%798.672.3%$414.82m
MDTMedtronic Plc -1.11%117.970.6%$406.84m
BSXBoston Scientific Corp. 2.35%37.521.0%$358.38m
DXCMDexCom, Inc. 0.93%367.507.8%$342.05m
BDXBecton, Dickinson & Co. -0.54%261.871.0%$290.87m
SYKStryker Corp. -0.59%243.761.3%$223.82m
QDELQuidel Corp. 2.78%218.497.7%$210.76m
ALGNAlign Technology, Inc. -3.64%543.816.4%$203.26m
AAgilent Technologies, Inc. -0.87%126.991.6%$194.37m
BAXBaxter International, Inc. 0.60%80.001.8%$181.12m
EWEdwards Lifesciences Corp. -0.99%87.230.4%$179.20m
ZBHZimmer Biomet Holdings, Inc. -0.23%163.091.7%$162.74m

Company Profile

Vericel Corp. engages in the research, product development, manufacture, and distribution of patient-specific, expanded cellular therapies for use in the treatment of patients with diseases. Its product portfolio includes MACI and Epicel. The MACI portfolio is FDA-approved product that applies the process of tissue engineering to grow cells on scaffolds using healthy cartilage tissue from the patient's own knee. The Epicel portfolio provide skin replacement for patients who have deep dermal or full thickness burns. The company was founded on March 24, 1989 and is headquartered in Cambridge, MA.